Protalix BioTherapeutics Inc (AMEX:PLX) shares, rose in value, with the stock price up by 1.05% to the previous day’s close as strong demand from buyers drove the stock to $2.39. Actively observing the price movement in the recent trading, the stock is buoying the session
Taking a look at stock we notice that its last check on previous day was $2.27 and 5Y monthly beta was reading 0.672 with its price kept floating in the range of $2.175 and $2.278 on the day. Considering stock’s 52-week price range provides that
Protalix BioTherapeutics Inc (AMEX:PLX) traded at $2.23 at close of the session on Monday, January 06 and made an upward move of 5.19% on its previous day’s price. Looking at the stock we see that its previous close was $2.12 and the beta (5Y monthly)
Protalix BioTherapeutics Inc (AMEX:PLX) shares, rose in value, with the stock price down by -0.83% to the previous day’s close as strong demand from buyers drove the stock to $1.78. Actively observing the price movement in the recent trading, the stock is buoying the session
Protalix Bio Therapeutics, Inc. (PLX) stock soared 46.67% in the pre-market trading session at the price of $1.54 after reporting topline data from the BALANCE clinical trial evaluating PRX–102. PLX is a biopharmaceutical firm that develops and commercializes therapeutic proteins using its plant cell-based ProCellEx
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.
